enVVeno Medical Corporation (NVNO): Kapitalisasi marang pendapatan

Simbol lan logo merek enVVeno Medical Corporation (NVNO)

Supplying clinics with sterile implants requires flawless logistics to save lives. The development of the vein bioprostheses ecosystem depends entirely on FDA approval. The P/S multiple demonstrates the balance between market price and operating revenue, where reflects the latest value of the metric. The price action of enVVeno Medical (NVNO) is constrained by strict regulators and unique patents for VBR valves.

NVNO Multiplikator P/S enVVeno Medical Corporation (04.07.2022 - 16.11.2026)

Rincian analitis perusahaan envveno.com (NVNO)

Analisis umum perusahaan:NVNO enVVeno Medical Corporation
Barang utama enVVeno Medical

The P/S ratio determines the market value of one dollar of revenue, allowing for an assessment of investment expectations regarding revenue growth rates. This metric compares total market capitalization to sales volume, revealing whether the market is overpaying for future success or underestimating the business. By analyzing the P/S ratio chart for enVVeno Medical (NVNO), one can observe the impact of venous valve clinical validation stages on market confidence. However, the lack of operating leverage and rising center costs are constraining the expansion of the multiple.

Pesaing enVVeno Medical

Kapitalisasi marang pendapatan Boston Scientific Corporation BSX|Multiplikator P/S EW (Edwards Lifesciences)|ResMed Corp (RMD) - Rega marang dodolan|Insulet Corp - Multiplikator P/S|ZBH (zimmerbiomet.com) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (NuVasive) - Multiplikator P/S|TransMedics Corp (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion, Inc. AORT|Multiplikator P/S ENOV (enovis.com)|Multiplikator P/S Integra LifeSciences Corp IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (IRADIMED CORPORATION) - Kapitalisasi marang pendapatan|Embecta Corp. - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Corp) - Multiplikator P/S|Rega marang dodolan AxoGen Inc AXGN|Rasio rega marang pendapatan SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Multiplikator rega marang pendapatan|Multiplikator P/S BVS (bioventus.com)|Multiplikator P/S OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - Multiplikator P/S|Koefisien rega marang pendapatan Blade Air Mobility SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Ophthalmic)|Rasio rega marang pendapatan clearpointneuro.com|Kapitalisasi marang pendapatan Stereotaxis, Inc. (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical - Kapitalisasi marang volume dodolan|VANI (Vivani Medical Inc) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan XTNT|NMTC (n1mtc.com) - Multiplikator P/S|Rega marang dodolan Modular Medical MODD|Rasio rega marang pendapatan myomo.com (MYO)|Rasio rega marang pendapatan COCH (envoymedical.com)|Rasio rega marang pendapatan Vivos Therapeutics Inc VVOS|Kapitalisasi marang volume dodolan SINT (sintx.com)|TNON - Rasio rega marang pendapatan|LFWD: Rasio rega marang pendapatan|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rega marang dodolan invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - Multiplikator P/S|Axonics Modulation Technologies (AXNX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan BIOL (Biolase, Inc.)|Dynatronics - Rasio kapitalisasi marang pendapatan|Paragon 28, Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan INVO Bio (INVO)